Mechanistically, differentiation of patient-derived GBM neurospheres, a process associated with the modulation of stemness and proliferative potential (22), lowered Mic60 as well as HIF1α mRNA levels (SI Appendix, Fig. S1D). The gene discussed is HIF1A; the disease is glioblastoma.